Rinvoq (upadacitinib)

pCPA File Number: 21574
Negotiation Status:
Concluded with an LOI
Indication(s):
Psoriatic Arthritis
Sponsor/Manufacturer:
AbbVie Corporation
CDA-AMC Project Number:
SR0658-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: